Early life adversity programs changes in central 5-HT neuronal function in adulthood

被引:74
作者
Gartside, SE [1 ]
Johnson, DA [1 ]
Leitch, MM [1 ]
Troakes, C [1 ]
Ingram, CD [1 ]
机构
[1] Newcastle Univ, Sch Med, Psychobiol Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
alpha(1)-adrenoceptor; 5-HT1A autoreceptor; dorsal raphe nucleus; programming; rat;
D O I
10.1046/j.1460-9568.2003.02668.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Early life adversity is associated with an increased incidence of psychiatric illness in adulthood. Although the mechanisms underlying this association are unclear, one possible substrate is brain 5-hydroxytryptamine neurotransmission, which is reportedly abnormal in several psychiatric disorders. This study examined the effect of a rat model of early life adversity, early maternal separation, on 5-hydroxytryptamine neurotransmission in adulthood. In vitro electrophysiological experiments revealed that, in early maternal separation rats compared with controls, the sensitivity of alpha(1)-adrenoceptors on 5-hydroxytryptamine neurons in the dorsal raphe nucleus was significantly reduced, whilst the sensitivity of 5-hydroxytryptamine(1A) receptors showed a nonsignificant trend to reduction. In in vivo microdialysis experiments, the 5-hydroxytryptamine(1A) receptor agonist-induced suppression of 5-hydroxytryptamine release in the frontal cortex was reduced in early maternal separation animals, suggesting desensitization of 5-hydroxytryptamine(1A) autoreceptors. There was no increase in basal 5-hydroxytryptamine in the frontal cortex as measured by microdialysis and a nonsignificant trend towards increased basal firing activity of classical (non-bursting) 5-hydroxytryptamine neurons in the dorsal raphe nucleus measured by in vivo electrophysiology. Finally, early maternal separation failed to alter expression of messenger ribonucleic acids coding for 5-hydroxytryptamine(1A) or alpha(1B) receptors in the dorsal raphe nucleus as measured by in situ hybridization histochemistry, suggesting that functional changes in receptor sensitivity observed are not due to changes in receptor gene transcription. The findings demonstrate that early life adversity programs changes in sensitivity of the two principal regulators of 5-hydroxytryptamine neuronal activity. Similar effects in humans may contribute to the increased incidence of psychiatric illness in individuals exposed to early life adversity.
引用
收藏
页码:2401 / 2408
页数:8
相关论文
共 55 条
[1]  
Abellán MT, 2000, SYNAPSE, V36, P21, DOI 10.1002/(SICI)1098-2396(200004)36:1<21::AID-SYN3>3.0.CO
[2]  
2-D
[3]   Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia [J].
Agid, O ;
Shapira, B ;
Zislin, J ;
Ritsner, M ;
Ritsner, M ;
Hanin, B ;
Murad, H ;
Troudart, T ;
Bloch, M ;
Heresco-Levy, U ;
Lerer, B .
MOLECULAR PSYCHIATRY, 1999, 4 (02) :163-172
[4]   Do early-life events permanently alter behavioral and hormonal responses to stressors? [J].
Anisman, H ;
Zaharia, MD ;
Meaney, MJ ;
Merali, Z .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1998, 16 (3-4) :149-164
[5]   LOCALIZED ALTERATIONS IN PRESYNAPTIC AND POSTSYNAPTIC SEROTONIN BINDING-SITES IN THE VENTROLATERAL PREFRONTAL CORTEX OF SUICIDE VICTIMS [J].
ARANGO, V ;
UNDERWOOD, MD ;
GUBBI, AV ;
MANN, JJ .
BRAIN RESEARCH, 1995, 688 (1-2) :121-133
[6]   SUPPRESSION OF FIRING ACTIVITY OF 5-HT NEURONS IN THE DORSAL RAPHE BY ALPHA-ADRENOCEPTOR ANTAGONISTS [J].
BARABAN, JM ;
AGHAJANIAN, GK .
NEUROPHARMACOLOGY, 1980, 19 (04) :355-363
[7]   State and trait abnormalities in serotonin function in major depression [J].
Bhagwagar, Z ;
Whale, R ;
Cowen, PJ .
BRITISH JOURNAL OF PSYCHIATRY, 2002, 180 :24-28
[8]  
Boylan CB, 2000, SOMATOSENS MOT RES, V17, P52
[9]  
BREIER A, 1988, ARCH GEN PSYCHIAT, V45, P987
[10]   THE INHIBITORY EFFECT OF 8-OH-DPAT ON THE FIRING ACTIVITY OF DORSAL RAPHE SEROTONINERGIC NEURONS IN RATS IS ATTENUATED BY LESION OF THE FRONTAL-CORTEX [J].
CECI, A ;
BASCHIROTTO, A ;
BORSINI, F .
NEUROPHARMACOLOGY, 1994, 33 (05) :709-713